<HashMap><database>ecrin-mdr-crc</database><scores/><additional><omics_type>Clinical</omics_type><study_start_year>2008</study_start_year><condition>Colorectal Carcinoma</condition><condition>Colorectal Tumors</condition><condition>Neoplasms, Colorectal</condition><condition>Rectal Neoplasms</condition><condition>Colorectal Cancer</condition><condition>Colorectal Neoplasms</condition><disease>Colorectal Carcinoma</disease><disease>Colorectal Tumors</disease><disease>Neoplasms, Colorectal</disease><disease>Rectal Neoplasms</disease><disease>Colorectal Cancer</disease><disease>Colorectal Neoplasms</disease><study_type>Interventional</study_type><full_dataset_link>https://newmdr.ecrin.org/Study/2057411</full_dataset_link><location>Netherlands</location><study_start_month>9</study_start_month><keyword>Radiosensitivity</keyword><keyword>Locally advanced rectal cancer</keyword><keyword>Chemoradiation</keyword><keyword>Nelfinavir</keyword><repository>ECRIN MDR</repository><study_status>Completed</study_status></additional><is_claimable>false</is_claimable><name>Nelfinavir, a Phase I/Phase II Rectal Cancer Study</name><description>The aim is to study safety and activity of nelfinavir , added to standard chemoradiotherapy in patients with locally advanced rectal cancer. Furthermore analysis of the effect of nelfinavir combined with chemoradiation on tumour tissue will be studied</description><dates><creation>2008-09-15</creation></dates><accession>2057411</accession><cross_references><ClinicalTrials___gov>NCT00704600</ClinicalTrials___gov></cross_references></HashMap>